Please enter and confirm your details
Graph of Forced Expiratory Volume (FEV1) compared with healthy 25 year old non-smoker, versus age in years.
- Learn how smoking affects your health.
- View lung models personalised with your smoking history.
- Find out your estimated lung function as you age.
- Click on each tab (below) for more information.
- Click on the blue vertical bar on the right to hide this panel and view the lungs. The blue vertical bar remains on the left and can be clicked to show this panel.
- Click on "How about my lungs?" (top-right) and enter details such as age, rate of smoking etc. which affect the lungs and their function. You can change these details at any time and see the effects immediately.
- View the 3-D lungs using the mouse or touch screen controls (see the tab below). You can switch between viewing 3-D Models of lung surfaces illustrating tar build-up, and airways showing differences in flow compared to healthy individuals.
- Adjust the time slider along the top of the screen to project to different ages. Click on the play button to animate.
- Open the "Estimated Lung Function" tab below and see how it changes with age and ceasing smoking.
- Find this helpful? You can share this page with your friends on Facebook, Google Plus and Twitter in the share tab.
- If you would like to give us some feedback, please use the form in the feedback tab.
Welcome and thanks for using the Turanga Lung Visualisation Application.
By using this app, you will:
How to use:
-
Reference:
- P. Boyle, N. Gray, J. Henningfield, J. Seffrin, W. Zatonski. Tobacco and Public Health: Science and Policy. Oxford University Press, Oxford, 2004
- Milivojevic-Poleksic, L., A. U. Wells, A. Moody, W. Fergusson, C. Tukuitonga, and J. Kolbe. Spirometric lung volumes in the adult Pacific Islander population: comparison with predicted values in a European population. Respirology. 6: 247-253, 2001.
- Between one-third to half of all patients with COPD have sleep disorders.
- At least one-third of patients have their social activities affected, and 58 percent were going out less.
- 22 percent needed regular help from family; 54 percent needed constant help.
Having COPD (chronic obstructive pulmonary disease) means that your airways are obstructed and the tissue inside the lungs is damaged.
Over 15 percent of all smokers are likely to become affected. Statistics also shows that 85 - 90 percent of COPD arises from smoking in New Zealand and is the fourth leading cause of death after cancer, heart disease and stroke.
Unlike asthma, COPD is not reversible, however, quitting smoking is the best way to protect lungs from futher damage and keep COPD symptoms from getting worse.
- Tobacco smoke contains more than 7,000 chemicals, about 70 of which are known to cause cancer.
- About 30,000 people die in New Zealand each year and around 5,000 of those are caused by smoking or second-hand smoke.
- Half of all regular smokers die early from a smoking related disease.
- Internationally, tobacco smoke is responsible for about 1 in 10 adult deaths.
- Smoking affects sporting performance negatively; exercising requires oxygen but smoking reduces oxygen intake.
-
Proportions of smoking-attributed diseases causing death.
Data above are findings of the Surgeon General's report in United State. Charts are produced by Kelly Burrowes.
- Research: Professor Merryn Tawhai, Dr Kelly Burrowes (ABI Lung Group) and Alan Wu (ABI software team)
- Advised by: Dr Merryn Tawhai, Dr Kelly Burrowes and Dr Richard Christie (ABI software team)
- Designed and Programmed by: Alan Wu (ABI software team)
This app is developed by the Auckland Bioengineering Insitute (ABI) and funded by Tobacco Control Research Tūranga.
Tobacco Control Research Tūranga is an organisation funded by the New Zealand government and it aims to reduce smoking in New Zealand.
3D models and its data are created/simulated using OpenCMISS software developed in ABI.
We would like to give special thanks to Professor Chris Bullen (National Institute for Health Innovation, University of Auckland), Associate Professor Marewa Glover (Research Centre for Māori Health & Development, Massey University) and Tobacco Control Research Tūranga.
